Policosanol (Reduchole22®) attenuates hypercholesterolemia via modulation of cholesterol biosynthesis and lipid metabolism in a high-fat diet-induced mouse model
Open Access
- 30 October 2025
- journal article
- Published by The Korean Society of Food Preservation in Food Science and Preservation
- Vol. 32 (5) , 836-851
Abstract
Policosanol, a mixture of long-chain aliphatic alcohols derived from sugarcane, is a promising nutraceutical for lowering blood cholesterol levels. Previous studies have reported cholesterol-lowering mechanisms, such as adenosine monophosphate-activated protein kinase (AMPK) activation, HMG-CoA reductase (HMGCR) inhibition, LDL receptor upregulation, and enhanced bile acid excretion. However, the underlying mechanisms related to additional aspects of cholesterol biosynthesis and lipid metabolism have not been fully elucidated. In this study, we evaluated the cholesterol-lowering effects of policosanol (Reduchole22®), a policosanol purified from sugarcane ethanol extract, in a high-fat diet (HFD)-induced mouse model. Our in vivo results showed that policosanol significantly reduced the atherogenic index in plasma and inhibited key enzymes involved in cholesterol synthesis, including HMGCR and acetyl-CoA acetyltransferase 1 (ACAT1), in both hepatic and arterial tissues. Our results confirmed previously reported mechanisms, including significant reductions in the atherogenic index, HMGCR and acetyl-CoA acetyltransferase 1 (ACAT1) inhibition, increased ATP-binding cassette transporter G5 (ABCG5) expression, and enhanced cholesterol 7α-hydroxylase (CYP7A1) activity, thus promoting cholesterol excretion. Notably, our study uniquely elucidates policosanol’s modulation of cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT), and paraoxonase 1 (PON1), providing deeper insights into HDL function, antioxidative defense mechanisms, and comprehensive lipid metabolism regulation. Our findings highlight policosanol as a distinct functional food ingredient for managing hypercholesterolemia and cardiovascular disease.Keywords
This publication has 39 references indexed in Scilit:
- Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeuticsBiomedicine & Pharmacotherapy, 2022
- Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseasesCell Metabolism, 2021
- Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J miceNutrition Research, 2017
- Sugarcane Production and Development of Sugar Industry in IndiaSugar Tech, 2016
- The regulation of ApoB metabolism by insulinTrends in Endocrinology & Metabolism, 2013
- Regulation of Cholesterol And Bile Acid Homeostasis by the Cholesterol 7α-Hydroxylase/Steroid Response Element-Binding Protein 2/Microrna-33A Axis in MiceHepatology, 2013
- Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-B and its DNA binding activityEuropean Journal of Pharmacology, 2008
- Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptorBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined HyperlipidemiaJAMA, 2006
- EFFECT OF POLICOSANOL SUCCESSIVE DOSE INCREASES ON PLATELET AGGREGATION IN HEALTHY VOLUNTEERSPharmacological Research, 1996